Reduced Protumorigenic Tumor-Associated Macrophages With Statin Use in Premalignant Human Lung Adenocarcinoma.
Esraa Al DujailyJuvenal BaenaMadhumita DasMarco SerenoClaire SmithTamihiro KamataLeah OfficerCatrin PritchardJohn P C Le QuesnePublished in: JNCI cancer spectrum (2019)
Statin use is associated with reduced numbers of protumorigenic TAMs within preinvasive lung adenocarcinoma and is related to reduced tumor invasiveness, suggesting a chemo-preventive effect in early tumor development. However, invasive disease is resistant to these effects, and no beneficial relationship between statin use and patient outcome is observed.